The Measles & Rubella Initiative is a global entity that provides funding and technical support directly to countries to address measles and rubella outbreaks. Through annual funding from Gavi, the Vaccine Alliance, and other supporters the M&RI partners are able to rapidly provide resources to countries experiencing outbreaks for targeted response activities including the purchase of vaccines and operational costs. M&RI has provided technical support to numerous countries working to prevent and stop measles outbreaks. This support is pivotal and sets M&RI and its five founding partners apart, making it all the more unique. In addition to technical support, M&RI Outbreak Response Funds have been provided to five countries (table.)

Countries Receiving M&RI Outbreak Response Funds in 2022


Country Target Population Date Approved
Afghanistan 1,229,926 February 23, 2022
DRC 2,678,973 March 24, 2022
Liberia 343,180 May 11, 2022
Yemen 1,355,142 May 20, 2022
Niger 992,259 July 11, 2022
Northwest Syria 535,688 July 12, 2022
Ethiopia 591,243 August 15, 2022
Cameroon 1,112,576 September 2, 2022
Zambia 2,024,604 November 28, 2022


Measles & Rubella | Media: NewsMeasles News

Read the latest news about ongoing immunization campaigns throughout the world.


Measles & Rubella interactive map thumbInteractive map

A dynamic visual aide showing current progress and challenges in the Measles & Rubella Initiative’s campaigns.


Measles Outbreaks Strategic Response Plan2021-2023 Measles Outbreaks Strategic Response Plan (MOSRP)

WHO together with its global and regional MR partners have identified a list of priority countries for enhanced outbreak preparedness and response support as part of the 2021-2023 Measles Outbreaks Strategic Response Plan (MOSRP). The list of priority countries is being regularly revised to account for changes on measles epidemiologic risk. You can find the latest version here.


M&RI Branding GuidelinesAdditional Links

Updated on November 30, 2022

Prelude Prelude Version 2.3.2